Treatment of Schizoaffective Disorder Using Mifepristone
This study tests the hypothesis that mifepristone will diminish cognitive distortion and alleviate psychosis in patients with schizoaffective disorder.
Stanford is not currently accepting new patients for this trial. You may want to check clinicaltrials.gov to see if other locations are recruiting.
- drug : Mifepristone
Phase: Phase 2/Phase 3
Ages Eligible For Study:
The subjects will be 30 inpatients or outpatients with schizoaffective disorder.